Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically S... (om our pivotal Phase IIIclinical studies...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant

Date:8/5/2008

om our pivotal Phase III clinical studies of the Isolagen Therapy," said Declan Daly, President and Chief Executive Officer of Isolagen. "We intend to file our Biologics License Application (BLA) with the FDA in early 2009 and continue to progress our ongoing Acne trial. I want to thank the clinical investigators and congratulate the Isolagen team for their exceptional performance and clinical achievement in this groundbreaking pivotal study confirming our belief in this innovative approach to aesthetic skin therapy."

About the Studies

The goal of the Phase III multicenter, double-blind, randomized, placebo- controlled studies was to demonstrate the efficacy of three treatments of Isolagen Therapy compared with placebo in the treatment of bilateral nasolabial folds, or wrinkles, six months following the last study treatment, using the co-primary endpoints of:

-- Subject Wrinkle Satisfaction Assessment: the person's own assessment of the wrinkles using a 5-point wrinkle satisfaction scale, and an

-- Evaluator Wrinkle Severity Assessment: the evaluator's live assessment of each of the bilateral nasolabial fold wrinkles at rest using a 6-point ordinal wrinkle severity scale with a photoguide as a reference tool.

Isolagen's Phase III studies for wrinkles were conducted under the Food and Drug Administration's (FDA) Special Protocol Assessment (SPA) regulations. The SPA process results in an agreement with the FDA that successful clinical trial results will form the basis of an efficacy claim for a marketing application. Although significant, the SPA does not guarantee approval of a BLA.

Further, Isolagen is currently conducting a Phase II/III clinical program to investigate the Isolagen Therapy for the treatment of moderate to severe acne scars.

Investor Conference Call

Isolagen will be hosting an investor conference call and webcast on Wednesday, August 6, 2008 at 8:00 a.m. Eastern Time to discuss the results of t
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
2. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
3. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
4. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
5. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
6. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
7. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
8. GeoVax Reports Progress on Its AIDS Vaccine Technology
9. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study

Post Your Comments:

(Date:5/24/2013)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ), ... will present at the Deutsche Bank 38 th Annual ... a.m. (ET). A live webcast of BD,s ... www.bd.com/investors and will be available for replay through ... BD is a leading global medical technology company that ...

(Date:5/24/2013)... 2013 Solta Medical, Inc. (NASDAQ: SLTM ... reported Dr. Edward W. Knowlton has ... effective immediately. Dr. Knowlton is the founder of Thermage, the ... director since 1996. "On behalf of the entire ... would like to thank Ed for his tireless dedication to ...

(Date:5/24/2013)... , May 24, 2013 Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...

Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2 Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2

[0] BD to Present at the Deutsche Bank 38th Annual Health Care Conference [0] Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.[0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference

... to a new market research report " ... (ICs, Thermostat, Thermistor, Resistive Temperature Detectors (RTDs), Thermocouple) & ... " published by MarketsandMarkets ( http://www.marketsandmarkets.com ), the ... was $3.27 billion and is expected to reach $4.51 ...

... 29, 2012 Cempra, Inc. (NASDAQ: CEMP ) ... and chief executive officer, will present at the Cowen ... a.m. EST, March 6, 2012, at The Boston Marriott ... overview of the company,s two leading antibiotic clinical programs, ...

Cached Medicine Technology:MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 2 MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 3 Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference 2

MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference

(Date:5/25/2013)... May 25 (HealthDay News) -- Many viruses and parasites ... and leptospirosis -- a bacteria-borne illness than can result ... at dog parks, according to a veterinarian. ... and even the air, said Dr. Susan Nelson, a ... Center. "Many of these serious diseases can be fatal, ...

(Date:5/25/2013)... May 25, 2013 Providing patients with their ... Doc team of weight management professionals. But, aside from educating ... effectively, Diet Doc’s hCG diets also provide patients, ... during childhood like bullying, more control over their lives by ... dealing with the underlying factors of weight gain derived from ...

(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...

(Date:5/25/2013)... BC (PRWEB) May 25, 2013 According ... the most beautiful and powerful women that ever lived. ... felt by some of the most powerful men in ... many beauty remedies to keep her skin glowing and ... made with bees- wax, maringa oil and cyprus grass. ...

(Date:5/25/2013)... For college students, few events ... they are turning to prescription stimulants like Adderall ... more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm . ... that students who pick up Adderall, “just to ... developing a physical and psychological dependency. While initially ...

Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2

[0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals

... Director of National Institutes of HealthNEW YORK, Feb. 3 ... the election of Dr. Elias A. Zerhouni , the ... leader in biomedical research, to its Board of Directors."We are ... of Directors," said Dr. Maria C. Freire , President ...

... to Chief Marketing Officer and PACS Industry Veteran ... ManagerWASHINGTON, Feb. 3 Compressus, Inc., leaders in ... team with the promotion of Janine Broda to ... Shawn Gibbons as vice president and general manager ...

... Feb. 3 The Female Health Company (NYSE Alternext: ... conference call to discuss its operating results for the ... (EST) on Tuesday, February 10, 2009. The Company ... the same day. Shareholders and other interested parties may ...

... Go Healthy, Inc. (Pink Sheets: GOHE) announced today that ... for development of major sports relationships at meetings held ... developing partnership with a sports entity, whose members are ... are a major extension of our agreement with Athletic ...

... the best way of spotting trouble, experts say , , ... the stool-based colon cancer tests -- recommended annually for ... to spot potential abnormalities, a German study finds. , ... tests for what is called fecal occult blood -- ...

... ALLEGAN, Mich., Feb. 3 Perrigo Company,(Nasdaq: PRGO ; TASE) today announced results for its fiscal year 2009 second,quarter and six months that ended December 27, ... Perrigo Company, ... Second Quarter Six Months, ... 2009 2008 2009 ...

Lasker Foundation Welcomes Elias Zerhouni to Board of Directors Compressus Bolsters Executive Team to Expand Interoperability Market Pioneered by MEDxConnect(TM)The Female Health Company Schedules First Quarter Conference Call for February 10, 2009 Go Healthy Participates in Super Bowl Events and Developing Sports Relationships Stool-Based Colon Cancer Tests Vary Widely in Accuracy Perrigo Reports Record Second Quarter Sales

Unique supportive clavicle splint. Features front closure design for convenience in application. Comfortable padding over clavicle area....

Indicated for treatment of patella instability...

... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...

... pain relief, stabilization and comfort for patient ... ,The Aspen® "Low Profile" LSO provides immediate ... tightened, using the LeverLatch mechanism, the brace ... of functional mobility and, in many cases, ...

Medicine Products:

Front Closure Clavicle Support 13 Patella Stabilizer w/Cor-Trak Buttress Comfor™ Clavicle Brace - Buckle Closure Aspen® LSO